Dr. Jinoos Yazdany, MD
Not yet claimedRheumatologist · Physician (MD)
San Francisco, CA
Dr. Jinoos Yazdany is a rheumatologist at UCSF who treats people with lupus and other rheumatic diseases. She leads the rheumatology division at Zuckerberg San Francisco General Hospital and works on national guidelines and quality-of-care measures.
About Dr. Jinoos Yazdany, MD
Updated Sep 20, 2026 · next review Dec 19, 2026Dr. Jinoos Yazdany is a rheumatologist in San Francisco. She is Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital (ZSFG) and the Alice Betts Endowed Professor of Medicine at UCSF. She sees patients at ZSFG and co-directs the UCSF Health Lupus Clinic, where she leads a clinic for people with systemic lupus erythematosus (SLE).
Her training includes an undergraduate degree from Stanford University, a medical degree from UCLA, and an MPH from Harvard University. She completed her internal medicine residency and rheumatology fellowship at UCSF.
Much of her public work is in lupus, health policy, and measuring quality of care. She co-authored the 2020 American College of Rheumatology guideline on reproductive health in rheumatic and musculoskeletal diseases, has worked on ACR quality measures for lupus and rheumatoid arthritis, and is the UCSF principal investigator of the COVID-19 Global Rheumatology Alliance Registry. In March 2025 she was named UCSF's first Executive Director of AI Monitoring in Clinical Care.
Public records show she received $35,806.78 in industry payments from 2021 to 2025 across 20 records in the CMS Open Payments database. The largest payers were AstraZeneca UK Limited, Pfizer, and UCB. Payments from drug and device companies to doctors are common and legal, and are reported publicly.
- Chief of rheumatology at ZSFG
- She is Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital and the Alice Betts Endowed Professor of Medicine at UCSF. profiles.ucsf.edu
- Lupus clinic focus
- She leads a dedicated clinic for people with systemic lupus erythematosus and co-directs the UCSF Health Lupus Clinic. ucsfhealth.org
- Training
- Stanford undergraduate, medical degree from UCLA, and MPH from Harvard University. rheumatology.ucsf.edu
- UCSF residency and fellowship
- She completed internal medicine residency and a rheumatology fellowship at UCSF. lupus.org
- National guideline co-author
- She co-authored the 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. deepblue.lib.umich.edu
- COVID-19 rheumatology registry
- She is principal investigator at UCSF of the COVID-19 Global Rheumatology Alliance Registry, an international data collection platform funded by the American College of Rheumatology. covidresearch.ucsf.edu
- AI monitoring role at UCSF
- In March 2025 she was named the inaugural Executive Director of AI Monitoring in Clinical Care at UCSF, leading the Impact Monitoring Platform (IMPACC). docit.ucsf.edu
- Lupus research awards
- She received the 2011 Mary Betty Stevens Young Investigator Prize from the Lupus Foundation of America and is listed on that organization's leadership page. lupus.org
- Elected to ASCI
- She was elected to the American Society for Clinical Investigation in 2021. data.the-asci.org
- Mentoring award
- She is the 2026 recipient of the UCSF Harold S. Luft Mentoring Award in health services and health policy research. healthpolicy.ucsf.edu
Worth knowing
- CMS Open Payments records show $35,806.78 in industry payments from 2021 to 2025 across 20 records, with the largest amounts from AstraZeneca UK Limited ($16,110), Pfizer ($7,037.50), and UCB ($4,970). Such payments are common and legal, and some of these companies make lupus and rheumatology drugs. openpaymentsdata.cms.gov
- An older third-party author bio describes her as a board-certified internist, but current board certification status was not verified against ABIM or state license records during this research. dummies.com
Industry payments (CMS Open Payments)
Open the CMS recordFederal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.
2021 to 2025
$35,807
20 payments
| 2021 | $3,300 |
| 2022 | $3,222 |
| 2023 | $11,742 |
| 2024 | $11,528 |
| 2025 | $6,015 |
Top payers
- AstraZeneca UK Limited$16,110
- PFIZER INC.$7,038
- UCB SA$4,970
- AstraZeneca Pharmaceuticals LP$3,140
- Amgen Inc.$2,327
Payment types
- Consulting Fee$32,221
- Honoraria$3,300
- Food and Beverage$227
- Education$59
A word of caution about these numbers
A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.
As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.
Sources: ucsfhealth.org · profiles.ucsf.edu · medicine.ucsf.edu · rheumatology.ucsf.edu · healthpolicy.ucsf.edu · rheumatology.ucsf.edu · lupus.org · docit.ucsf.edu. Something wrong or out of date? Tell us and we will correct it.
Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.
Practice location
UCSF Health Lupus Clinic
1001 Potrero Ave Fl 2
San Francisco, CA 94110
Open in maps